CNR2 and neoplasm: In addition, recent studies have reported that increased expression of the human epidermal growth factor 2 (HER2)-CB2 receptor heteromer in breast tumours is associated with lower disease-free survival in patients [48] and that lower CB2 levels in tumour-associated macrophages from colorectal cancer patients are associated with longer survival [57].